In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Actavis

Division of Allergan PLC
www.actavis.us

Latest From Actavis

India’s Intas Launches Trastuzumab At A 65% Discount

India’s Intas Pharmaceuticals will undercut domestic rivals by marketing its new biosimilar trastuzumab at a price 65% cheaper than the current market cost.

Launches Biosimilars

Defusing US Opioid Crisis Offers Orexo "Strong Growth Potential" Says CEO

The CEO of Swedish addiction and pain specialist Orexo tells Scrip its top drug Zubsolv will grow strongly in coming years to address the opioid crisis in the US, and that revenues will be further boosted by novel pipeline therapies likely to be commercialized in coming years.

Business Strategies Commercial

AbbVie's 'Unjustified' Humira Settlements Divide Market, Claims Class Action

First suit challenging biosimilar litigation settlements ratchets up pressure on AbbVie's "patent thicket" and licensing strategy.

BioPharmaceutical Biosimilars

AbbVie's 'Unjustified' Humira Settlements Divide Market, Class Action Claims

First suit challenging biosimilar litigation settlements ratchets up pressure on AbbVie's "patent thicket" and licensing strategy.

BioPharmaceutical Biosimilars
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
    • OTC, Consumer
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Allergan PLC
  • Senior Management
  • Hafrun Fridriksdottir, VP, R&D
    Stephen Gallagher, VP, Fin.
    Michael Perfetto, VP, Sales & Mktg.
  • Contact Info
  • Actavis
    Phone: (973) 993-4500
    60 Columbia Rd.
    Bldg. B
    Morristown, NJ 07960
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register